EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing ' s Sarcoma

Leah A. Owen, Ashley A. Kowalewski, Stephen L. Lessnick · 2008

Read EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing ' s Sarcoma by Leah A. Owen, Ashley A. Kowalewski, Stephen L. Lessnick (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001965.txt.

Description

Leah Owen and co-authors traced how a cancer-driving fusion protein mutes genes, in a 2008 PLOS ONE study. The protein, EWS/FLI, is the master driver of Ewing sarcoma, a bone cancer of the young. Gene studies in a sarcoma cell line had shown the fusion switches more genes off than on. That makes it act in large part as a repressor.

The team followed one target, a gene switch called NKX2.2. As the title states, EWS/FLI represses genes through NKX2.2 during the shift to cancer. Naming the middleman gives drug work a new point of attack in a cancer with few options.

Catalog record

CREATORLeah A. Owen, Ashley A. Kowalewski, Stephen L. Lessnick
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001965

Browse the full library · About the Tower of Babel